New study: Stargardt Disease Therapeutics and In-depth Research on Market Size, Share, Trends, Emerging Growth
Stargardt disease is an inherited juvenile macular degeneration that causes vision loss. The signs and symptoms of the disease typically appear in late childhood or early adulthood and worsen with time. The most common cause of the disease is mutations in the ABCA4 gene. People suffering from stargardt disease might notice grey or black color in the middle of eye, or eyes may be more sensitive to bright light. Others may even have symptoms of color blindness. The prevalence for the disease is low, reported at around 1 in 8,000-10,000 people globally, as stated by National Eye Institute in April 2015. Hence, the disease falls into rare disease category. Till date, there is no treatment available, though there are multiple therapies in pipeline.
Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1314
Robust pipeline for each treatment type that may get regulatory approval over the forecast period is expected to boost the growth of stargardt disease therapeutics market
Treatment options for Stargardt disease include drug, gene therapy and stem cell therapy. There are products in each of these category currently in clinical trials. For instance, Nightstar Therapeutics expanded its pipeline with gene therapy program for Stargardt Disease treatment in November 2017. In drug category, certain companies have received orphan drug designation from U.S. FDA. For instance, in January 2017, Acucela Inc. received orphan drug designation for its leading product emixustat for the treatment of stargardt disease. In October 2017, Lin BioScience also received orphan n drug designation for its leading product LBS-008 for the treatment of Stargardt Disease. Furthermore, companies such as Astellas Pharma Inc. is working on stem cell therapy for Stargardt disease. With the approval of some of the therapy that are currently in pipeline, the global stargardt disease therapeutics market is expected to witness rapid growth over the forecast period.
Stargardt Disease Therapeutics Market Taxonomy:
By Treatment Type:
Stem Cell Therapy
By Stages of Development:
North America is expected to hold a dominant position in the global stargardt disease therapeutics market
Acucela Inc. and Lin Bioscience have received orphan drug designation for their respective products, and are headquartered in U.S. Other companies such as Astellas Pharma Inc, Copernicus Therapeutics Inc. and Sanofi S.A. are either U.S.-based or have considerable presence in U.S. This positions North America as a major market for stargardt disease. Europe is expected to hold second position in stargardt disease therapeutics market as companies like Nightstar therapeutics has shown interest in developing treatment for stargardt disease. In Asia Pacific region, Japan is home to companies such as Astellas Pharma Inc. Also, major Japan-based pharmaceutical companies are working with small-size Company operating in this area. For instance, Otsuka Pharmaceutical Co., Ltd., a Japan-based company, has continued its collaboration agreement with Acucela Inc., a clinical stage company working on stargardt disease, since 2008.
Key players operating in stargardt disease therapeutics market include Nemus Bioscience Inc., Acucela Inc., Katairo, Ocata Therapeutics Inc., Sanofi, Alkeus Pharmaceuticals Inc., Astellas Pharma Inc., Copernicus Therapeutics Inc., Grupo Ferrer Internacional SA, Iris Pharma, Ophthotech Corp, ProQR Therapeutics NV.
Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/1314
Important Features that are under offering & key highlights of the report:
1) What all companies are currently profiled in the report?
The report Contain the Major Key Players currently profiled in this market.
** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.
2) Can we add or profiled new company as per our need?
Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by research team depending upon the difficulty of survey.
** Data availability will be confirmed by research in case of privately held company. Upto 3 players can be added at no added cost.
3) What all regional segmentation covered? Can specific country of interest be added?
Currently, research report gives special attention and focus on following regions:
North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain etc), South America (Brazil, Argentina etc) & Middle East & Africa (Saudi Arabia, South Africa etc)
** One country of specific interest can be included at no added cost. For inclusion of more regional segment quote may vary.
4) Can inclusion of additional Segmentation / Market breakdown is possible?
Yes, inclusion of additional segmentation / Market breakdown is possible subject to data availability and difficulty of survey. However a detailed requirement needs to be shared with our research before giving final confirmation to client.
** Depending upon the requirement the deliverable time and quote will vary.
To comprehend 2018-2026 Stargardt Disease Therapeutics Market dynamics in the world mainly, the worldwide 2018-2026 Stargardt Disease Therapeutics Market is analyzed across major global regions. CMI also provides customized specific regional and country-level reports for the following areas.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New study: Stargardt Disease Therapeutics and In-depth Research on Market Size, Share, Trends, Emerging Growth here
News-ID: 1307459 • Views: 789
More Releases from Coherent Market Insights (CMI)
Empty Capsules Market : Global Future Estimation, Outlook & Complete Strategic A …
Hard gelatin capsules are made using gelatin derived from animal bones and skins. These capsules are made in two halves: a lower-diameter "body" that is filled and then sealed using a higher-diameter "cap". Hard gelatin capsules are used for encapsulation of dry, powdered ingredients or miniature pellets, semi-solids, and liquids. Statistics: The global empty capsules market is estimated to account for US$ 3,122.5 Mn in terms of value by the end of
Bubble Tea Market is Expected to Grow at a Healthy CAGR with Top players
Bubble Tea is also popular by the names boba milk tea, tapioca tea, pearl milk tea, boba tea, bubble drink, tapioca pearl drink, momi tea, QQ, and milk tea. Bubble tea was invented as tea-based drink in Taichung, Taiwan’s tea shops in 1980s. Bubble tea drinks contain a tea based mixed with milk and fruit flavor. The taste of bubble tea comes from the small chewy tapioca balls known as
LATEST NEWS: Catering and Food Service Contractor Market is taking Foot Back due …
Catering is a very critical part of the business, especially for network carriers serving long distances. Meal design and meal planning are important processes of catering services. According to International Air Transport Association (IATA), catering planning and catering operations are important areas of activities of catering services. Growing tourism industry is one of the major factors driving growth of the global catering and food service contractor market. Download Sample Copy
Trends Of Scottish Whisky Market Reviewed For 2020 With Industry Outlook To 2027
Scottish whisky is a malt whisky, which is made up of grains. Originally, Scottish whisky was processed using barley, but around 18th century, wheat and rye-based Scottish whisky was made. On the basis of product type, Scottish whisky is segmented into single malt, blended malt, blended, single grain, blended grain, and organic whisky. The major ingredients of Scottish whisky are malted barley or other cereals such as maize and wheat
More Releases for Stargardt
Global Stargardt Disease Therapeutics Market Remains Afloat amid COVID-19 Pandem …
KD Market Insights (KDMI) recently published market research report on the Global Stargardt Disease Therapeutics market, this market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trends, along with various key insights into the market research report. The report on global Stargardt Disease Therapeutics market demonstrates the important aspects that are anticipated to shape the growth of the market over the forecast period. The study also
Global Juvenile Degeneration (Stargardt Disease) Market Forecast to 2025
Juvenile Degeneration (Stargardt Disease) Market report describes the thorough and collective examination of the Juvenile Degeneration (Stargardt Disease) industry during the past, present and conjecture periods. All the business verticals like driving market situation, regional Juvenile Degeneration (Stargardt Disease) nearness, and improvement openings are clarified. Top players of the Juvenile Degeneration (Stargardt Disease) industry, their business strategies, and growth opportunities are covered in this report. A report is incomplete without
Stargardt Disease Pharmaceutical and Healthcare Analysis Information
Introduction Juvenile Macular Degeneration is the genetic eye disorder that affects the vision further leading to vision loss. Generally, this disorder affects the specialized light-sensitive tissue present in the retina. Precisely, this type of macular degeneration affects the center of the retina which is knewn as macula. The function of macula is to add sharpness to the central vision. This region is responsible for handling detailed tasks such as recognizing
North America is expected to hold a dominant position in the global stargardt di …
Stargardt disease is an inherited juvenile macular degeneration that causes vision loss. The signs and symptoms of the disease typically appear in late childhood or early adulthood, and worsen with time. The most common cause of the disease is mutations in the ABCA4 gene. People suffering from stargardt disease might notice grey or black colour in the middle of eye, or eyes may be more sensitive to bright light. Others
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline landscape. Juvenile macular degeneration is a series of inherited eye disorders
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017
Market Research Hub's latest Pharmaceutical and “Healthcare disease pipeline guide Juvenile Macular Degeneration Pipeline Review”, H2 2017, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline landscape. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305539 Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form of juvenile macular degeneration is Stargardt disease. Stargardt's disease is an inherited autosomal recessive syndrome.